KASH PETER M 4

4 · Nile Therapeutics, Inc. · Filed Jul 16, 2009

Form 4

Period: 2009-07-15

Director

Transactions

Other
Warrant (Right to Buy)
2009-07-15+125,000→ 125,000 total
Exercise: $1.38From: 2009-07-15Exp: 2019-07-15→ Common Stock (125,000 underlying)

Holdings

Common Stock
1,596,208
Common Stock
(indirect: By Spouse)
496,589
Warrant (Right to Buy)
Exercise: $2.71From: 2007-09-17Exp: 2011-09-17→ Common Stock (1,052 underlying)
1,052
Stock Option (Right to Buy)
Exercise: $4.50Exp: 2018-01-25→ Common Stock (60,000 underlying)
60,000
Warrant (Right to Buy)
Exercise: $2.28From: 2009-07-07Exp: 2014-07-07→ Common Stock (49,407 underlying)
49,407
Common Stock
(indirect: By Foundation)
165,530
Warrant (Right to Buy)
Exercise: $1.25From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,704 underlying)
24,704
Stock Option (Right to Buy)
Exercise: $0.93From: 2010-01-01Exp: 2018-12-22→ Common Stock (35,000 underlying)
35,000
Warrant (Right to Buy)
Exercise: $1.71From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,703 underlying)
24,703

Footnotes (3)

[F1]Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
[F2]The shares subject to the option vest in three equal installments on September 17, 2008, September 17, 2009, and September 2010.
[F3]Allocated from warrant issued to a placement agent.

Documents

1 file